Alexandra Vitale

Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.; Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center], Siena, Italy.

50 publications 2025 – 2026 ORCID

What does Alexandra Vitale research?

Dr. Vitale studies various conditions that involve cancer, particularly focusing on how certain diseases like VEXAS syndrome and liver diseases impact patient outcomes. She explores the effectiveness of treatments like liver transplants and transarterial chemoembolization, identifying which patients are most likely to benefit from these therapies. Additionally, she researches the risk factors that lead to serious complications in patients with Behçet's disease, helping to pinpoint those who may develop more severe symptoms over time.

Key findings

  • Patients receiving a liver transplant for colorectal cancer with liver metastases lived about 51 months post-surgery, consistent with previous trials showing 5-year survival rates.
  • Individuals with VEXAS syndrome have a nearly twice the risk (1.93 times) of developing cancer compared to similar patients, particularly if they have certain gene mutations or high inflammation levels.
  • Among 890 hepatocellular carcinoma patients treated with transarterial chemoembolization, 26.1% showed cancer spread during follow-up, with a tumor burden score above 3.66 predicting a 10.4% spread risk.
  • In a study of 328 Behçet's patients, 25% who showed only skin and mucous membrane symptoms later developed serious complications, notably those with major oral sores facing a 12.76 times higher risk.
  • Of 328 patients with initial skin and mouth symptoms of Behçet's disease, 11% later developed eye inflammation, with family history and Arab ethnicity increasing risk.

Frequently asked questions

Does Dr. Vitale study liver cancer?
Yes, she researches the effectiveness of treatments for liver cancer, particularly focusing on transplants and the risk of cancer spreading.
What conditions related to VEXAS syndrome does Dr. Vitale research?
Dr. Vitale studies the cancer risks associated with VEXAS syndrome and how to distinguish it from similar syndromes.
Is Dr. Vitale's work relevant to patients with Behçet's disease?
Yes, she investigates risk factors and complications in Behçet's disease, helping to identify patients who may develop serious health issues.
What treatments has Dr. Vitale researched for Schnitzler syndrome?
She has studied the effectiveness of IL-1 targeting agents, finding significant improvement rates with treatments like anakinra.
How can Dr. Vitale's research help doctors?
Her research provides insights into patient outcomes and risk factors, allowing healthcare providers to make better decisions about treatment and monitoring.

Publications in plain English

Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.

2026

Journal of hepatology

Stern C, Loustaud-Ratti V, Yurdaydin C, Brancaccio G, Jachs M +41 more

Plain English
This study looked at the safety and effectiveness of a treatment called REP 2139-Mg for patients with advanced liver disease caused by hepatitis D virus (HDV). Out of 33 patients treated, 70% saw a significant decline in HDV levels, and 58% had no detectable virus after completing the treatment. Additionally, 27% lost a related virus marker (HBsAg), and half of the patients with follow-up had normalized liver enzyme levels. This is important because it shows that REP could be a viable option for patients who have not responded to other treatments, especially those with serious liver conditions. Who this helps: This helps patients with chronic hepatitis D and advanced liver disease.

PubMed

Pharmacological Modulation of Autophagy Corrects Cellular Defects in Pediatric Crohn's Disease.

2026

Molecular and cellular biology

Creoli M, Buono P, Cenni S, Casertano M, Vitale A +10 more

Plain English
This study focused on how two treatments, Tat-beclin-1 and carbamazepine (CBZ), could improve certain immune cell functions in children with Crohn's disease, a serious gut condition. The researchers found that after treatment, immune cells (dendritic cells) in all patients processed bacterial particles better, and the most vulnerable patients showed even more improvement. Additionally, in tissue samples from children with Crohn's, treatment led to a significant decrease in certain cell components, suggesting better cell function. Who this helps: This benefits children diagnosed with Crohn's disease.

PubMed

Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry.

2026

American journal of ophthalmology

Gaggiano C, DE-LA-Torre A, Guerriero S, Tierradentro-Alape R, Ragab G +46 more

Plain English
This study looked at how noninfectious uveitis, an eye condition, affects women at different stages of their reproductive life. Researchers found that women in early puberty and perimenopause had the highest rates of flare-ups, with an average of 1.0 relapses in early puberty and 1.0 in perimenopause. This information is important because it helps doctors understand when women might be at greater risk for this condition, allowing for better treatment and management. Who this helps: This helps patients, particularly women experiencing puberty or approaching menopause.

PubMed

Pathogen-Associated Visual Outcomes Following Postprocedure Endophthalmitis.

2026

American journal of ophthalmology

Ather M, Lyden E, Zhan Y, Haliyur R, Sinha A +9 more

Plain English
This research looked at the visual outcomes of 240 adult patients who developed a severe eye infection called postprocedure acute endophthalmitis after eye surgeries from 2012 to 2022. It found that patients infected with more harmful bacteria (like Streptococcus) had much worse vision results compared to those infected with less harmful bacteria (average vision score was 2.14 vs. 0.77). These findings highlight the importance of quickly identifying the type of bacteria causing the infection to improve treatment and patient outcomes. Who this helps: This helps patients who undergo eye surgeries.

PubMed

The Yin-Yang of HCC management: Reconciling therapeutic hierarchy and transplant benefit in real-world evidence.

2026

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Vitale A, Piscaglia F, Sangiovanni A, Cabibbo G, Russo FP +4 more

PubMed

Association between C-reactive protein and adverse events in secondary cardiovascular prevention: A systematic review and meta-analysis of prognostic factor studies.

2026

Atherosclerosis

Piccolo R, Laino A, Vitale AP, Franzone A, Giacoppo D +3 more

Plain English
This research examined the connection between a substance called C-reactive protein (CRP) and the risk of serious heart-related events in patients who have a history of heart disease. The study found that higher levels of CRP significantly increased the risk of major heart issues and death; specifically, those with elevated CRP levels were 55% more likely to experience major cardiovascular events and 92% more likely to die from any cause. This matters because measuring CRP levels could help doctors identify patients who are at greater risk for future heart problems and tailor their treatment accordingly. Who this helps: This helps patients with established heart disease and their doctors.

PubMed

Revisiting Methodologic Paradigms in Local Therapies for Hepatocellular Carcinoma: Insights From the SURF Study.

2026

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Vitale A, Mansournia MA, Ponziani FR, Rovetta A

PubMed

Reevaluating Pediatric Nailbed Injuries: Are We Overtreating Simple Cases?

2026

Journal of hand surgery global online

Reed E, Bautista C, French M, Vitale A, Winterton C +3 more

Plain English
This study looked at common fingertip injuries in children, specifically focusing on nailbed injuries, to see if many of the treatments being used were actually necessary. Researchers reviewed data from 239 patients and found that regardless of how the injuries were treated—whether through surgical repair, a less invasive method, or no aggressive treatment—the rates of complications or infections were very similar, ranging from 0% to 3%. This matters because it suggests that many children with simple nailbed injuries might do just as well with less treatment, which could save time and reduce the need for more complex medical procedures. Who this helps: This helps patients and their families by reducing unnecessary medical interventions and stress.

PubMed

Phase Behavior and Proton Conductivity in Crown Ether-Based Supramolecular Sodium Hydrogen Sulfate Complexes.

2026

Crystal growth & design

Vitale A, Ocak S, Staffolani A, Soavi F, Bordignon S +2 more

Plain English
This study looked at how certain chemical complexes made from sodium hydrogen sulfate and two crown ether compounds behave in solid form and how well they conduct protons. Researchers used techniques like X-ray analysis to observe their structures and found that these complexes can undergo solid-to-solid transitions, which significantly boost their proton conductivity. One compound showed particularly strong performance, demonstrating enhanced conductivity useful in various applications. Who this helps: This benefits researchers and engineers working on better battery technologies and fuel cells.

PubMed

Health-care professions' silent complicity in Palestine's health crisis - Authors' reply.

2026

Lancet (London, England)

Vitale A, Abu Hilal M, Gumbs AA, Cillo U, Frigerio I

PubMed

Frailty in Hepatocellular Carcinoma: An Unsettled Clinical Challenge.

2026

Current oncology (Toronto, Ont.)

Bonato A, Guerra P, Vitale A, Martini A,

Plain English
This study focuses on frailty in patients with hepatocellular carcinoma (HCC), a type of liver cancer. Researchers found that frailty, often seen in people with liver cirrhosis, can affect treatment decisions for HCC patients, but there isn't enough evidence to use standard tools to assess frailty in these cases. Recognizing frailty better could lead to more effective treatment plans based on individual needs. Who this helps: This helps patients with liver cancer by improving treatment approaches.

PubMed

Molecular Identification and RNA-Based Management of Fungal Plant Pathogens: From PCR to CRISPR/Cas9.

2026

International journal of molecular sciences

Ansari RA, Rezaee Danesh Y, Castello I, Vitale A

Plain English
This research paper studies how modern techniques can help identify and manage fungal diseases that harm crops. It highlights the effectiveness of new methods like PCR and CRISPR/Cas9, which allow for quick detection of specific fungi directly from plant tissues and enable targeted treatments without relying on harmful chemicals. These advancements could significantly improve crop protection, making it more precise, sustainable, and adaptable to different environments. Who this helps: Farmers and agricultural scientists.

PubMed

Detection of Idiosyncratic Gaze-Fingerprint Signatures in Humans.

2026

Psychological science

Crockford SK, Satta E, Severino I, Fiacchino D, Vitale A +4 more

Plain English
Researchers studied whether people have a unique "gaze fingerprint," or a specific way of looking at images, by examining how 700 individuals viewed complex pictures. They found that about 52% to 63% of the time, people could be identified uniquely based on their gaze patterns, which is much higher than random chance. This matters because identifying these gaze patterns could help in understanding traits related to neurodevelopment, particularly in individuals with autistic traits. Who this helps: This research benefits psychologists and clinicians working with patients on the autism spectrum.

PubMed

Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regression.

2026

ESMO open

Iannantuono GM, Giovagnoli T, Mastrantoni L, Gyawali B, Floudas CS +11 more

Plain English
This study looked at how including cancer patients with a performance status of 2 (PS 2), who are generally less healthy, affects the outcomes of major cancer trials. Researchers analyzed 36 trials and found that while PS 2 patients experienced more serious side effects and had a higher risk of treatment-related issues, their overall survival and progression-free survival rates were similar to those of healthier patients. This matters because including these patients in trials can provide better insights into how treatments work for a broader group of cancer patients. Who this helps: This helps both patients and doctors by ensuring that treatment data is more reflective of all cancer patients.

PubMed

Disulfide-Induced Inhibition of Epoxy Cationic Photopolymerization: A Route to Maskless Patterning.

2026

Macromolecular rapid communications

Spessa A, Bongiovanni R, Vitale A

Plain English
This study examined how a specific compound, disulfide diol, affects the process of creating patterns in epoxy materials using light. The researchers found that by using a higher ratio of sulfur to epoxy, they could effectively stop the polymerization process, allowing for precise patterning with features as small as 200 micrometers. This research is important because it provides a new way to create detailed designs in epoxy coatings without needing masks, making the manufacturing process more efficient. Who this helps: This benefits manufacturers and engineers working with epoxy materials.

PubMed

Dual targeted therapy with biologic agents and small molecules in refractory inflammatory arthritis: clinical outcomes and safety profile.

2026

Internal and emergency medicine

Caggiano V, Vitale A, Sbalchiero J, Placido F, Mazzei MA +4 more

Plain English
This study looked at a treatment approach called dual targeted therapy for patients with severe inflammatory arthritis who did not respond to standard medications. Researchers followed eight patients and found that after treatment, inflammation markers significantly decreased—specifically, a drop in the average ESR from 42 to 16.1 mm/h and CRP from 1.52 to 0.35 mg/dL. This approach not only improved disease activity for most patients, but it also allowed for a substantial reduction in steroid use without any harmful side effects, highlighting its potential for helping those with stubborn cases of the disease. Who this helps: Patients with rheumatoid arthritis, psoriatic arthritis, and other related conditions who struggle with treatment-resistant symptoms.

PubMed

From algorithms to adaptive frameworks: from square to circle in hepatocellular carcinoma management.

2026

Hepatobiliary surgery and nutrition

Vitale A, Cabibbo G, Bargellini I, Rimassa L, Cillo U

PubMed

The use of non-TNF targeted biologics in Behçet's Disease: Real-life data from the International AIDA Network Behçet's Disease Registry.

2026

Rheumatology (Oxford, England)

Sevik G, Lopalco G, Iannone F, Frassi M, Piga M +21 more

Plain English
This study looked at how well certain new medications, known as non-TNF targeted biologics, work for patients with Behçet's disease who do not respond to standard treatments. It found that 65 patients showed varying levels of improvement after using these new therapies: 34.7% improved with Anakinra for skin symptoms, 73.3% for joint problems, and 77.7% for eye issues. These findings are important because they highlight alternative options that can help patients who struggle with traditional treatments, allowing for more personalized care. Who this helps: This helps patients with Behçet's disease who don't respond to standard therapy.

PubMed

3D "Emboli" Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis.

2026

Cancer research communications

Balamurugan K, Mikolaj MR, Weiss JM, Holewinski RJ, Fan Y +14 more

Plain English
This study looked at different ways to grow breast cancer cells in the lab, specifically using two 3D culture methods: mammosphere culture and emboli culture. Researchers found that the emboli culture made the cancer cells behave more like real tumors, showing slower growth but a strong ability to spread to the lungs. This matters because it helps scientists understand how breast cancer spreads and could lead to better treatments that target these behaviors. Who this helps: This research benefits cancer researchers and ultimately patients with breast cancer.

PubMed

Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study.

2026

Scientific reports

Gentileschi S, Terribili R, Gaggiano C, Fiorentini E, Cometi L +14 more

Plain English
This study looked at the effectiveness of a medication called ixekizumab for treating psoriatic arthritis (PsA) in patients over two years. The researchers found that ixekizumab significantly reduced disease activity and improved patients' quality of life, with 46.7% achieving remission and 93.3% showing low disease activity after 24 months. Additionally, 82.1% of patients continued with the treatment after one year, indicating that it’s effective for long-term use, although women had slightly lower retention rates. Who this helps: This benefits patients with psoriatic arthritis, particularly those seeking effective long-term treatment options.

PubMed

Liquid Deposition Modeling of Biobased Epoxy Composites: Natural Fillers as Rheology Modifiers and Reinforcements.

2026

ACS omega

Albertini E, Fragkogiannis C, Tsantilis L, Arrigo R, Vitale A +2 more

Plain English
This research focused on improving 3D printing materials made from natural sources by adding different types of fillers to a plant-based epoxy resin. The study found that using 22% microcrystalline cellulose (MCC) and 1% microfibrillated cellulose (MFC) made the mixture easier to print and strengthened the final product, achieving a tensile strength of 1.31 MPa after it was cured. This is important because it shows that using natural materials can lead to effective and environmentally friendly options for 3D printing. Who this helps: This helps manufacturers and designers looking for sustainable materials for 3D printing.

PubMed

GSCs in the Transdifferentiation Phenomenon: Focus on CAR-T-Based Therapy.

2026

Cells

Di Marco M, Lo Giudice A, Cecala FC, David S, Caruso Bavisotto C +3 more

Plain English
This research looked at glioblastoma, a very deadly brain tumor, focusing on glioblastoma stem cells (GSCs) that help the tumor grow and resist treatment. The study found that GSCs can change into different cell types that support blood vessel formation, which helps the tumor survive. Using CAR-T therapy, a type of immunotherapy, could specifically target and kill these GSCs, potentially leading to better treatment outcomes and reducing tumor growth. Who this helps: This research benefits patients with glioblastoma and their doctors by offering insights into new treatment options.

PubMed

Curvature Dynamics of PEGDA Asymmetric Networks via Frontal Photopolymerization: Effect of Chain Length and Optical Attenuation.

2026

Macromolecules

Ridwan MG, Dizman HM, Bentley I, Vitale A, Cabral JT

Plain English
This study looked at how different lengths of PEGDA molecules affect the solidification and bending of materials made using a technique called frontal photopolymerization. The researchers found that longer molecules solidified faster with less light exposure—specifically, they needed 20% less light time to harden effectively. These insights are important because they can help create better materials for uses like tissue engineering or 3D printing by effectively controlling how they bend and change shape. Who this helps: This benefits researchers and developers in materials science and engineering, particularly those working on medical applications.

PubMed

Polymorphism-dependent room-temperature phosphorescence of a persulfurated benzene.

2026

Chemical communications (Cambridge, England)

d'Agostino S, Vitale A, Kapadiya Y, Gingras M, Negri F +2 more

Plain English
This study looked at two forms of a chemical called persulfurated benzene and how they glow in the dark at room temperature. The researchers found that the two forms, named polymorphs I and II, produce different colors of light due to how their molecules are arranged in crystals. Understanding these relationships helps develop better materials for applications like lighting and sensors. Who this helps: This benefits researchers and companies looking to improve materials for lighting and sensor technologies.

PubMed

Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real-World Evidence in a Rapidly Evolving Therapeutic Landscape.

2026

European journal of haematology

Mancuso K, Masci S, Talarico M, Vitale A, Barbato S +14 more

Plain English
This study looked at how effective a treatment called melflufen combined with dexamethasone is for patients with multiple myeloma who have already undergone multiple previous therapies. Out of 17 patients treated, 41% responded well to the treatment, with patients showing an average progression-free survival of 3.7 months, and responders having a longer average of 9.0 months. This research is important because it offers additional options for treating patients whose cancer is hard to manage, especially those who have exhausted other therapies. Who this helps: This helps patients with multiple myeloma who have not responded to standard treatments.

PubMed

Argon laser demarcation of AIDS-related cytomegalovirus retinitis in resource-limited setting.

2026

International ophthalmology

Hassman LM, Oo KT, Din ZM, Larochelle M, Tun N +5 more

Plain English
This study looked at using argon laser treatment to manage vision problems caused by cytomegalovirus (CMV) in people with AIDS in Myanmar, where resources are limited. They treated 45 eyes and found that none experienced retinal detachment or loss of central vision over three years. In comparison, patients who already had retinal detachment before surgery faced worse outcomes, with 42% losing more vision. Who this helps: Patients with AIDS-related vision issues in resource-limited areas.

PubMed

Organizational change readiness for team science: a pathway framework for team science success.

2026

Frontiers in psychology

Lotrecchiano GR, DiazGranados D, Vitale A, Browne-Huntt M

Plain English
This paper studied how to better prepare people for collaborative work in science, known as team science. The authors found that there is a significant gap in the support system for budding team scientists, meaning there isn't a solid pathway for training and career advancement in this field. Creating structured training and professional development opportunities is essential for helping scientists work together effectively and meet the changing demands of different employers. Who this helps: This benefits students and early-career scientists looking to build successful careers in collaborative scientific environments.

PubMed

VEXAS syndrome in adults: A narrative review of genomic pathogenesis, multisystem phenotypes, diagnostic algorithms, and emerging therapeutic strategies.

2026

Autoimmunity reviews

Vitale A, Cifuentes-González C, Gentile M, Cataldi G, Agrawal K +3 more

Plain English
Researchers studied VEXAS syndrome, a newly recognized condition that affects adults, mainly older males, due to mutations in a specific gene called UBA1. They found that over 300 cases have been reported since 2020, with patients often experiencing a range of symptoms like painful inflammation and blood issues. It's important because understanding this syndrome better can lead to more effective diagnosing and treatment options, such as using JAK inhibitors, although current treatment approaches vary widely. Who this helps: This helps patients with VEXAS syndrome and their doctors.

PubMed

Irreversible Ocular and Systemic Damage in ROSAH Syndrome.

2026

Ophthalmology and therapy

Fabiani C, Caggiano V, Sbalchiero J, Gaggiano C, Cardamone C +7 more

Plain English
This study looked at four patients from two families in Italy who have ROSAH syndrome, which affects vision and other body systems. The researchers found that all patients had serious eye issues, like retinal dystrophy and complications like glaucoma, and one patient developed severe kidney problems due to a rare condition called reactive amyloidosis. Early diagnosis is essential to prevent further damage and improve treatments for these patients. Who this helps: This helps patients with ROSAH syndrome and their doctors by improving understanding and guiding treatment options.

PubMed

Temporal Patterns and Factors Associated with Early Termination in Phase 1 Clinical Trials for Solid Tumors.

2026

Journal of the National Cancer Institute

Iannantuono GM, Sganga S, Giovagnoli T, Mastrantoni L, Floudas CS +20 more

Plain English
This study looked at why early termination (ET) happens in early-phase clinical trials for solid tumors, analyzing 2,301 studies from 2018 to 2023. The researchers found that over half (51.1%) of phase 1 trials were stopped early due to decisions made by the sponsors, while later phase trials often ended due to insufficient patient recruitment. This research is important because it highlights specific factors like funding sources and the type of cancer that affect the likelihood of trials being discontinued, suggesting potential areas for improvement to keep these trials running. Who this helps: This helps researchers and sponsors by identifying factors that lead to trial success or failure.

PubMed

Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network.

2026

Frontiers in immunology

Caggiano V, Sbalchiero J, Frassi M, Crisafulli F, Cavazzana I +52 more

Plain English
This study looked at how recurring fevers affect patients with VEXAS syndrome, a serious autoinflammatory condition. Researchers found that about 75% of the 87 patients had recurrent fever, which was linked to a higher risk of death (99.41%) and serious organ issues, especially with the heart (99.99%), lungs (99.98%), and digestive system (97.5%). The presence of these fevers made it less likely for treatments to work fully but more likely to lead to partial improvements, helping to inform better treatment plans for patients. Who this helps: Patients with VEXAS syndrome and their healthcare providers.

PubMed

Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study.

2026

Alimentary pharmacology & therapeutics

Pinto E, Pelizzaro F, Simeon V, Bucci L, Gambato M +29 more

Plain English
This study looked at how the tumor burden score (TBS) can predict the likelihood of cancer spreading beyond the liver in patients with hepatocellular carcinoma (HCC) who received a specific treatment called transarterial chemoembolization (TACE). Among 890 patients, 7.2% had cancer spread shortly after treatment, but this rose to 26.1% during follow-up; those with a higher TBS (above 3.66) were more likely to see cancer spread, with 10.4% facing it first compared to just 3.6% for those with a lower score. Understanding TBS can help doctors identify which patients are at higher risk for the cancer spreading, allowing for better monitoring and treatment plans. Who this helps: This helps doctors in assessing and managing the risk for patients with liver cancer.

PubMed

The Risk of Developing Ocular Involvement Among Behçet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet's Disease Registry.

2026

Ophthalmology and therapy

Vitale A, Caggiano V, Sbalchiero J, Lopalco G, Ragab G +94 more

Plain English
This study looked at patients with Behçet's disease who started with skin and mouth issues to see how many developed eye problems later. Among 328 patients, 36 (11%) went on to develop eye inflammation. Factors like having a family history of the disease and being of Arab ethnicity significantly increased the chances of eye involvement, while fewer ulcers and being of European descent appeared to lower the risk. Who this helps: This information benefits patients with Behçet's disease and their doctors by identifying who may be at higher risk for serious eye complications.

PubMed

Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry.

2026

Rheumatology (Oxford, England)

Vitale A, Gavioli F, Caggiano V, Sbalchiero J, Lopalco G +95 more

Plain English
This study examined 328 people with Behçet's disease who initially showed only skin and mucous membrane symptoms. It found that 25% of these patients later developed serious organ involvement, with specific factors like major oral sores greatly increasing that risk—individuals with both major and minor oral sores faced a 12.76 times higher risk of serious complications. Understanding these risks is crucial for monitoring and managing Behçet's patients to help prevent serious health issues. Who this helps: This aids doctors in identifying which Behçet's patients are at higher risk for complications.

PubMed

VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.

2026

Seminars in arthritis and rheumatism

Gavioli F, Caggiano V, Sbalchiero J, Frassi M, Crisafulli F +58 more

Plain English
This study looked at VEXAS syndrome, a serious condition that causes chronic inflammation and affects blood cells, to see how it relates to cancer risk. Researchers found that patients with VEXAS have nearly twice the risk of developing cancer (1.93 times) compared to those with other similar conditions. Specifically, certain factors like a specific gene mutation and high inflammation markers were linked to even higher risks of cancer in these patients. Who this helps: This information benefits patients with VEXAS syndrome and their doctors, as it highlights the need for close monitoring for cancer.

PubMed

Benchmarking the real-world transplant benefit in unresectable colorectal liver metastases: A preliminary external validity assessment of the TransMet trial.

2026

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Cillo U, Vitale A, Lanari J, Rovetta A, Mansournia MA +8 more

Plain English
This study looked at how effective liver transplants are for patients with colorectal cancer that has spread to the liver and cannot be surgically removed. It found that patients who received a liver transplant lived about 51 months after the procedure, which is similar to the 5-year survival reported in earlier trials. The research also identified certain factors, like specific genetic mutations and sex, that made survival after transplantation worse, underscoring the need for refined patient selection for transplants. Who this helps: This helps doctors and healthcare providers make better decisions about who should receive liver transplants for this condition.

PubMed

The Impact of Intraoperative Methadone on Perioperative Opioid Requirements in Autologous Free Flap Breast Reconstruction.

2025

Journal of reconstructive microsurgery

Somers S, Vitale A, Dadzie A, French M, Eddington D +2 more

Plain English
This study explored whether giving patients methadone during breast reconstruction surgery would lower their overall need for opioids after the procedure. Researchers found that patients who received methadone used significantly fewer opioids both during surgery (23.7 mg vs. 44.5 mg) and on the first two days after surgery, as well as throughout their hospital stay, with total usage at 87.4 mg compared to 139.1 mg for those who did not receive methadone. This is important because it shows that methadone can help manage pain effectively while potentially reducing reliance on stronger opioids, which can have serious side effects. Who this helps: This helps patients undergoing breast reconstruction by potentially reducing their pain medication needs.

PubMed

Advances in Magnetic UAV Sensing: A Comparative Study of the MagNimbus and MagArrow Magnetometers.

2025

Sensors (Basel, Switzerland)

Accomando F, Barone A, Mercogliano F, Milano M, Vitale A +2 more

Plain English
This study looked at two types of magnetometers (MagNimbus and MagArrow) used in drones to find buried pipes in a specific area in Southern Italy. They found that the MagNimbus system is more stable and efficient, while the MagArrow system provides clearer signals but can be less stable. Optimizing these systems is important for improving the quality of data collected for detecting buried objects. Who this helps: This research benefits engineers and geologists working in infrastructure and environmental assessments.

PubMed

Concomitant inflammatory bowel disease impairs biologic response and increases residual symptom burden in psoriatic arthritis.

2025

Seminars in arthritis and rheumatism

Morrone M, Venerito V, Giannotta MG, Principi MB, Aquila PD +3 more

Plain English
This study looked at how having inflammatory bowel disease (IBD) affects the treatment response in people with psoriatic arthritis (PsA) who are starting biologic therapies. Researchers found that only 32% of patients with both PsA and IBD achieved a state of minimal disease activity after six months, compared to 58% of those who only had PsA. This matters because it highlights that patients with both conditions not only respond less well to treatment but also experience more ongoing symptoms, indicating a need for specialized treatment plans for them. Who this helps: This helps patients with psoriatic arthritis who also have inflammatory bowel disease.

PubMed

Transverse Mandibular Distraction Technique for Complex Craniofacial Reconstruction.

2025

Plastic and reconstructive surgery. Global open

French M, Bautista C, Winterton C, Chen J, Vitale A +5 more

Plain English
This study explored a new method for widening the lower jaw in patients with jaw abnormalities, specifically using a device that attaches to the teeth. In one case, after surgery, the patient successfully expanded their jaw over time and showed improvement in jaw alignment and chewing ability. This method is important because it offers a reliable solution for correcting severe jaw shape issues without many complications. Who this helps: Patients with jaw deformities, especially children and adolescents who are still growing.

PubMed

Epidemiological Evidence Supports the Role of Microbial Interactions in Polymicrobial UTI Infections Revealed by In Vitro Research.

2025

Antibiotics (Basel, Switzerland)

Piatti G, Mannini A, Vitale A, Bruzzone M, Schito AM +1 more

Plain English
This study looked at urinary tract infections (UTIs) to understand how different germs interact when present together. Out of over 24,000 urine samples from patients, about 7,200 tested positive for infection, with 75% having one type of germ (monomicrobial) and 25% having multiple types (polymicrobial). The researchers found that infections with multiple germs showed a wider variety of microorganisms and that some germs thrived better together than alone, which suggests these mixed infections might be more common due to these interactions. Who this helps: This benefits patients with urinary tract infections by providing insights into how mixed infections occur.

PubMed

The clinical management of adult patients with Familial Mediterranean fever.

2025

Expert review of clinical immunology

Ruscitti P, Caso F, Vitale A, Giacomelli R, Cantarini L

Plain English
This study looked at how to manage adult patients with Familial Mediterranean Fever (FMF), a genetic condition that causes repeated episodes of inflammation. Researchers found that while FMF usually begins in childhood, it can also start in adulthood, with symptoms that may not fit typical inflammatory disease patterns. They emphasized the need for better awareness and monitoring of long-term problems, like liver and kidney issues, as well as fertility concerns that adults with FMF might face. Who this helps: This information benefits patients with FMF and their healthcare providers.

PubMed

Sjögren's disease and concomitant fibromyalgia: clinical profile and implications for disease activity assessment.

2025

Internal and emergency medicine

Stano S, Venerito V, Domanico D, Iacovantuono M, Urgesi E +8 more

Plain English
This study looked at how common fibromyalgia (FM) is in patients with Sjögren's disease (SjD) and how the two conditions affect patients' symptoms. Among 267 patients with SjD, 30% also had FM, and those with both conditions reported significantly more severe symptoms, including pain and fatigue, with a symptom score of 7.7 compared to 6.0 for those without FM. This matters because it shows that while the overall disease activity may be similar, patients with FM experience greater discomfort, which can help guide better treatment approaches. Who this helps: This helps patients with Sjögren's disease and fibromyalgia by improving symptom management and reducing unnecessary medication use.

PubMed

Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mg.

2025

Journal of thrombosis and thrombolysis

Piccolo R, Laino A, Vitale AP, Canonico ME, Avvedimento M +13 more

Plain English
This study looked at how different doses of a heart medication called ticagrelor affect elderly men and women who have had a heart attack. Researchers found that both the 60 mg and 90 mg doses had similar effects on blood platelets, meaning they worked equally well in preventing blood clots for both sexes, even though the lower dose resulted in lower levels of the medication in the blood. This is important because it suggests that older patients might receive effective treatment with a smaller dose, which could reduce potential side effects. Who this helps: This helps elderly patients with heart conditions and their doctors in making informed treatment choices.

PubMed

Therapeutic walks beyond the ICU: a safe strategy to enhance emotional well-being in critically ill patients with prolonged hospitalization.

2025

Critical care (London, England)

Gilgado DI, Bertozzi M, Pérez J, Cardoso GP, Piaggio V +3 more

PubMed

Ultrasound Evaluation of Plantar Fascia in Individuals with Charcot-Marie-Tooth Disease: An Exploratory Study.

2025

Life (Basel, Switzerland)

Vallario N, Vitale A, Zeni A, Di Ciesco E, Martire E +6 more

Plain English
This study looked at how the plantar fascia, a tissue in the foot, is affected in people with Charcot-Marie-Tooth disease (CMTd), which is a common inherited condition that can cause foot problems and difficulties with movement. Researchers used ultrasound to examine 26 people with CMTd and found that while the thickness of the plantar fascia didn't increase, there were noticeable differences between the left and right feet. They also found that changes in the plantar fascia were linked to older age, more severe disease, and poorer physical performance, showing that these changes are more related to the natural progression of the disease rather than inflammation. Who this helps: This research benefits patients with CMTd and their doctors by providing better understanding and potential imaging tools for managing the condition.

PubMed

Cannabis Use is Related to Anhedonia in Adolescents With Diverse Mood and Anxiety Symptoms.

2025

JAACAP open

Nguyen TNB, Ely BA, Vitale A, Roske C, Richard JT +2 more

Plain English
This study looked at the relationship between cannabis use and a condition called anhedonia, which is a difficulty in feeling pleasure, in adolescents facing mood and anxiety challenges. Researchers found that out of 153 participants, those who used cannabis regularly reported greater anticipatory anhedonia compared to those who had never used it or had only tried it once. This is significant because understanding this connection can help guide better treatment strategies for young people struggling with mood disorders. Who this helps: This research benefits adolescents with mood and anxiety disorders, as well as their doctors and mental health professionals.

PubMed

Impact of constant low gas pressure on cardiopulmonary parameters and surgical outcomes in extraperitoneal total nerve-sparing robot-assisted radical prostatectomy.

2025

Frontiers in surgery

Cochetti G, Paladini A, Vitale A, Mearini M, Simonte R +4 more

Plain English
This study looked at the effects of using a lower gas pressure (8 mmHg) during a specific type of prostate surgery called extraperitoneal robot-assisted radical prostatectomy, compared to the standard pressure of 12 mmHg. Researchers found that while the lower pressure did lead to higher levels of carbon dioxide in the body during surgery, it did not result in more complications or longer operation times. This matters because it suggests that using a lower gas pressure can make this surgery safer for patients, especially those with breathing problems. Who this helps: This helps patients with prostate cancer, particularly those who also have chronic lung conditions.

PubMed

IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry.

2025

Clinical and experimental rheumatology

Calabrese L, Cartocci A, Vitale A, Martín-Nares E, D'Onghia M +32 more

Plain English
This study looked at how well two drugs that block a protein called IL-1 work for patients with Schnitzler syndrome, a rare disease. The researchers found that patients treated with anakinra showed a complete or partial improvement 73% of the time, while those on canakinumab improved about 67% of the time. Most patients continued their treatment for up to five years, with about 85% staying on anakinra after one year, but some stopped because the treatment stopped working for them. Who this helps: This benefits patients with Schnitzler syndrome, helping them understand the effectiveness of their treatment options.

PubMed

Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries.

2025

Frontiers in medicine

Caggiano V, Sbalchiero J, Frassi M, Martín-Nares E, Hinojosa-Azaola A +57 more

Plain English
This study focused on figuring out how to tell apart VEXAS syndrome from Schnitzler’s syndrome, since they share many similarities. Researchers looked at 37 patients (19 with VEXAS and 18 with Schnitzler's) and found that age, anemia, and swollen lymph nodes were key signs that could indicate VEXAS syndrome. For example, older patients with swollen lymph nodes were significantly more likely to have VEXAS, with a risk factor of nearly 68 times more than those with Schnitzler's. Who this helps: This benefits doctors diagnosing these conditions and their patients by providing clearer indicators for more accurate treatment.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.